{"transactions":[{"id":856003,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-06T21:16:38.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests one-third on March 5, 2027 and 1/24th monthly thereafter."}],"balance_after":330000,"derivative":{"exercise_price":2.86,"expiration_date":"2036-03-05","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001831127-26-000005","document":"form4-03062026_090335.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000183112726000005/form4-03062026_090335.xml","form_type":"4"}},{"id":929903,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-28T02:30:02.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":30453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date."}],"balance_after":68786,"source":{"system":"sec-edgar","filing":"0001213900-26-008472","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390026008472/ownership.xml","form_type":"4"}},{"id":979155,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T21:05:15.000Z","date":"2025-12-04","kind":"grant","planned":false,"acquired":true,"shares":460000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests one-third on December 4, 2026 and 1/24th monthly thereafter."}],"balance_after":460000,"derivative":{"exercise_price":6.14,"expiration_date":"2035-12-04","underlying":"Common Stock","underlying_shares":460000},"source":{"system":"sec-edgar","filing":"0001831127-25-000005","document":"form4-12052025_041207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000183112725000005/form4-12052025_041207.xml","form_type":"4"}},{"id":1036234,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-09-19T01:45:02.000Z","date":"2025-09-16","kind":"exercise","planned":false,"acquired":false,"shares":13333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board."}],"balance_after":6667,"derivative":{"exercise_price":8.32,"expiration_date":"2031-01-10","underlying":"Common Stock","underlying_shares":13333},"source":{"system":"sec-edgar","filing":"0001213900-25-089216","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025089216/ownership.xml","form_type":"4"}},{"id":1036233,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-19T01:45:02.000Z","date":"2025-09-16","kind":"exercise","planned":false,"acquired":true,"shares":13333,"price":8.32,"value":110930.56,"ownership":{"direct":true},"balance_after":38333,"source":{"system":"sec-edgar","filing":"0001213900-25-089216","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025089216/ownership.xml","form_type":"4"}},{"id":1097984,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-07-01T18:00:33.000Z","date":"2025-06-27","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests one-third on June 27, 2026 and 1/24th monthly thereafter."}],"balance_after":40000,"derivative":{"exercise_price":4.71,"expiration_date":"2035-06-27","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-018643","document":"form4-07012025_060730.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588925018643/form4-07012025_060730.xml","form_type":"4"}},{"id":1297421,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-23T02:04:17.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares represent restricted stock units issued on January 17, 2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 17, 2026, subject to continued service on the vesting date."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001213900-25-005667","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025005667/ownership.xml","form_type":"4"}},{"id":1565852,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-03-20T20:22:57.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board."}],"balance_after":30000,"derivative":{"exercise_price":3.55,"expiration_date":"2034-03-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899140-24-000321","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000089914024000321/form4.xml","form_type":"4"}},{"id":1612515,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-28T17:40:36.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":138835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest 100% on February 26, 2025, one year following the grant date."}],"balance_after":138835,"derivative":{"exercise_price":0.357,"expiration_date":"2034-02-26","underlying":"Common Stock","underlying_shares":138835},"source":{"system":"sec-edgar","filing":"0001415889-24-005666","document":"form4-02282024_050227.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588924005666/form4-02282024_050227.xml","form_type":"4"}},{"id":1802034,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-08-18T11:05:06.000Z","date":"2023-08-17","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.2498,"value":31245.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.00 to $1.25, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. (\"Virios\"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":57461,"source":{"system":"sec-edgar","filing":"0001415889-23-012375","document":"form4-08182023_070801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588923012375/form4-08182023_070801.xml","form_type":"4"}},{"id":2013745,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-15T17:54:16.000Z","date":"2022-12-12","kind":"grant","acquired":true,"shares":410000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person filed a Form 4 on December 14, 2022 which incorrectly reported that on December 12, 2022 he was granted 480,000 Stock Options. This Form 4 amendment is being filed for the purpose of amending and restating the Form 4 to reflect that the reporting person was granted 410,000 Stock Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests one-third on December 12, 2023 and 1/24th monthly thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The reporting person filed a Form 4 on December 14, 2022 which incorrectly reported that on December 12, 2022 he was granted 480,000 Stock Options. This Form 4 amendment is being filed for the purpose of amending and restating the Form 4 to reflect that the reporting person was granted 410,000 Stock Options."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person filed a Form 4 on December 14, 2022 which incorrectly reported that on December 12, 2022 he was granted 480,000 Stock Options. This Form 4 amendment is being filed for the purpose of amending and restating the Form 4 to reflect that the reporting person was granted 410,000 Stock Options."}],"balance_after":410000,"derivative":{"exercise_price":0.2789,"expiration_date":"2032-12-12","underlying":"Common Stock","underlying_shares":410000},"source":{"system":"sec-edgar","filing":"0001415889-23-002583","document":"form4a-02152023_050206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588923002583/form4a-02152023_050206.xml","form_type":"4/A","original_submission_date":"2022-12-14"}},{"id":2052264,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2023-01-18T23:56:13.000Z","date":"2023-01-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on 1/14/2023. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board."}],"balance_after":20000,"derivative":{"exercise_price":4.43,"expiration_date":"2033-01-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-23-003549","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390023003549/ownership.xml","form_type":"4"}},{"id":2086620,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2022-12-14T23:33:01.000Z","date":"2022-12-12","kind":"grant","acquired":true,"shares":480000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests one-third on December 12, 2023 and 1/24th monthly thereafter."}],"balance_after":480000,"derivative":{"exercise_price":0.2789,"expiration_date":"2032-12-12","underlying":"Common Stock","underlying_shares":480000},"source":{"system":"sec-edgar","filing":"0001415889-22-012561","document":"form4-12142022_111237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588922012561/form4-12142022_111237.xml","form_type":"4"}},{"id":2218772,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-30T17:38:55.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests one-third on June 23, 2023 and 1/24th monthly thereafter."}],"balance_after":90000,"derivative":{"exercise_price":4.23,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001415889-22-007076","document":"form4-06302022_100647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588922007076/form4-06302022_100647.xml","form_type":"4"}},{"id":2258493,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-05-24T14:24:56.000Z","date":"2022-05-23","kind":"purchase","acquired":true,"shares":7500,"price":4.52,"value":33900.0,"ownership":{"direct":true},"balance_after":32461,"source":{"system":"sec-edgar","filing":"0001415889-22-005567","document":"form4-05242022_070548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588922005567/form4-05242022_070548.xml","form_type":"4"}},{"id":2378232,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2022-02-23T21:23:05.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board."}],"balance_after":20000,"derivative":{"exercise_price":4.03,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-22-008962","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390022008962/doc4.xml","form_type":"4"}},{"id":2461264,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-12-22T18:23:58.000Z","date":"2021-12-21","kind":"purchase","acquired":true,"shares":5000,"price":5.523,"value":27615.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.395 to $5.708, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. (\"Virios\"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":24961,"source":{"system":"sec-edgar","filing":"0001415889-21-006172","document":"form4-12222021_101249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588921006172/form4-12222021_101249.xml","form_type":"4"}},{"id":2659132,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-22T20:58:47.000Z","date":"2021-06-21","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests one-third on June 21, 2022 and 1/24th monthly thereafter."}],"balance_after":60000,"derivative":{"exercise_price":6.78,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001415889-21-003142","document":"form4-06222021_010611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588921003142/form4-06222021_010611.xml","form_type":"4"}},{"id":2754541,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-07T17:59:46.000Z","date":"2021-04-06","kind":"purchase","acquired":true,"shares":382,"price":6.3576,"value":2428.6032,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This purchase was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2021."}],"balance_after":19961,"source":{"system":"sec-edgar","filing":"0001104659-21-047486","document":"tm2112418-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000110465921047486/tm2112418-1_4seq1.xml","form_type":"4"}},{"id":2755924,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-07T01:56:16.000Z","date":"2021-04-05","kind":"purchase","acquired":true,"shares":15675,"price":6.1727,"value":96757.0725,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This purchase was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2021."}],"balance_after":19579,"source":{"system":"sec-edgar","filing":"0001104659-21-047253","document":"tm2112349d1_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000110465921047253/tm2112349d1_4a.xml","form_type":"4/A","original_submission_date":"2021-04-06"}},{"id":2755922,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-06T19:38:39.000Z","date":"2021-04-05","kind":"purchase","acquired":true,"shares":15675,"price":6.1727,"value":96757.0725,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2021."}],"balance_after":19579,"source":{"system":"sec-edgar","filing":"0001104659-21-047069","document":"tm2112297-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000110465921047069/tm2112297-1_4.xml","form_type":"4"}},{"id":2908129,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2021-01-14T01:19:05.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board."}],"balance_after":20000,"derivative":{"exercise_price":8.32,"expiration_date":"2031-01-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-21-002062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390021002062/doc4.xml","form_type":"4"}},{"id":2909761,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-13T00:45:58.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":21796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock options granted pursuant to the reporting person's employment agreement.  Pursuant to that employment agreement, the reporting person was entitled to receive a total of 435,921 stock options. In error, the Issuer previously granted only 414,125. This grant was made solely to correct the error in the number of stock options granted under the reporting person's employment agreement."}],"balance_after":435921,"derivative":{"exercise_price":10,"exercise_date":"2021-01-11","expiration_date":"2030-12-21","underlying":"Common Stock","underlying_shares":21796},"source":{"system":"sec-edgar","filing":"0001104659-21-003576","document":"tm212264-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000110465921003576/tm212264-5_4seq1.xml","form_type":"4"}},{"id":2912415,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2021-01-09T00:23:42.000Z","date":"2021-01-06","kind":"exercise","acquired":false,"shares":801,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":7.8,"exercise_date":"2020-12-16","expiration_date":"2021-01-15","underlying":"Common Stock","underlying_shares":801},"source":{"system":"sec-edgar","filing":"0001104659-21-002579","document":"tm212264-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000110465921002579/tm212264-1_4seq1.xml","form_type":"4"}},{"id":2912414,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-09T00:23:42.000Z","date":"2021-01-06","kind":"exercise","acquired":true,"shares":801,"price":7.8,"value":6247.8,"ownership":{"direct":true},"balance_after":3904,"source":{"system":"sec-edgar","filing":"0001104659-21-002579","document":"tm212264-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000110465921002579/tm212264-1_4seq1.xml","form_type":"4"}},{"id":2936395,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-22T01:12:37.000Z","date":"2020-12-21","kind":"grant","acquired":true,"shares":414125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":414125,"derivative":{"exercise_price":10,"exercise_date":"2020-12-21","expiration_date":"2030-12-21","underlying":"Common Stock","underlying_shares":414125},"source":{"system":"sec-edgar","filing":"0001104659-20-138202","document":"tm2039099-4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000110465920138202/tm2039099-4_4.xml","form_type":"4"}},{"id":2992549,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2020-11-04T22:06:01.000Z","date":"2020-11-02","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on 11/02/2020 and are subject to monthly vesting in equal installments during the one-year period beginning on December 2, 2020, subject to continued service on the board."}],"balance_after":2500,"derivative":{"exercise_price":5,"expiration_date":"2030-11-02","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001213900-20-035045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390020035045/doc4.xml","form_type":"4"}},{"id":2992548,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":62302,"kind":"person","name":"Duncan Gregory Scott","position":1,"cik":"0001831127","reported_name":"Duncan Gregory Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2020-11-04T22:06:01.000Z","date":"2020-11-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on 11/02/2020. One-third of the options vested on the date of grant. One-third of the options will vest on each of the first and second anniversaries of the date of grant, subject to continued service on the board."}],"balance_after":20000,"derivative":{"exercise_price":5,"expiration_date":"2030-11-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-20-035045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390020035045/doc4.xml","form_type":"4"}}]}